New mass spectrometry (MS) methods are changing how drug firms monitor quality. And, according to the author of a new study, collaboration between suppliers, software developers, and regulators will ...
There’s more to RNA analysis than determining nucleotide sequences. There’s also the detection of post-transcriptional modifications (PTxMs). More than 170 PTxMs are known, and they seem to affect ...
MINNEAPOLIS--(BUSINESS WIRE)--ASMS 2022 – Waters Corporation (NYSE:WAT) today unveiled new instruments, software and product enhancements to drive drug discovery and development at the American ...
Thermo Fisher Scientific has absorbed HighChem, the Bratislava, Slovakia-based developer and trademark holder of the Mass Frontier mass spectrometry software used to identify the structures of small ...
A new algorithm for analyzing protein mass spectrometry data has uncovered four types of previously undescribed protein modifications introduced during sample preparation (J. Proteome Res., DOI: ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
SAN JOSE, Calif., June 6, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed the acquisition of HighChem, Ltd., a leading ...
Once upon a time, mass spectrometers were open-platform devices that could be tweaked as new applications arose. Today’s mass specs, though, are tightly engineered black boxes: sample in, data out.
The rapid evolution of high-resolution mass spectrometry (MS) has necessitated the development of increasingly sophisticated proteomics software to translate complex spectral data into biologically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results